Upgrade to SI Premium - Free Trial

Freedom Broker Upgrades Biogen (BIIB) to Buy, raises PT to $245

May 1, 2026 1:05 PM
Freedom Broker analyst Ilya Zubkov upgraded Biogen (NASDAQ: BIIB) from Hold to Buy with a price target of $245.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades